The COVID Medicines Delivery Unit (CMDU gives new COVID-19 treatments for patients, from the NCL sector, who are at the highest risk in the community. These treatments involve intravenous infusion of neutralising monoclonal antibodies (nMABs) or oral antiviral treatments, which are given to high-risk patients who have had a positive PCR test. Based at University College Hospital, the service is the only one of its kind in the north-central London sector.

Service management


Former operations room
Ground floor of the Tower,
University College Hospital
235 Euston Road

Patients will be discharged on the same day of the treatment unless identified as being clinically unwell enough to be admitted to the hospital. If there is a worsening of symptoms, the first contact should be their GP or 111.